Loading…

Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis

Sarcomas, rare and with lower survival rates than common tumors, offer insights into healthcare efficiency via the analysis of the total interval of the diagnostic pathway, combining the patient interval (time between the first symptom and visit with a physician) and diagnostic interval (time betwee...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2023-10, Vol.15 (19), p.4892
Main Authors: Elyes, Maria, Heesen, Philip, Schelling, Georg, Bode-Lesniewska, Beata, Studer, Gabriela, Fuchs, Bruno
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c466t-7d41b8f2741423ad5e8fc856bb8594a3fd4938f531f5cbad4a8fa92b612a2b483
cites cdi_FETCH-LOGICAL-c466t-7d41b8f2741423ad5e8fc856bb8594a3fd4938f531f5cbad4a8fa92b612a2b483
container_end_page
container_issue 19
container_start_page 4892
container_title Cancers
container_volume 15
creator Elyes, Maria
Heesen, Philip
Schelling, Georg
Bode-Lesniewska, Beata
Studer, Gabriela
Fuchs, Bruno
description Sarcomas, rare and with lower survival rates than common tumors, offer insights into healthcare efficiency via the analysis of the total interval of the diagnostic pathway, combining the patient interval (time between the first symptom and visit with a physician) and diagnostic interval (time between first physician visit and histological diagnosis). Switzerland’s healthcare system, Europe’s costliest, lacks research on treating rare conditions, like mesenchymal tumors. This study examines the total interval of the diagnostic pathway for optimization strategies. Analyzing a dataset of 1028 patients presented from 2018 to 2021 to the Swiss Sarcoma Board (MDT/SB-SSN), this retrospective analysis delves into bone sarcoma (BS), soft-tissue sarcoma (STS), and their benign counterparts. Demographic and treatment data were extracted from medical records. The patient interval accounted for the largest proportion of the total interval and secondary care interval for the largest proportion of the diagnostic interval. Age, grade, and localization could be elicited as influencing factors of the length of different components of the total interval. An increasing age and tumor size, as well as the axial localization, could be elicited as factors increasing the probability of sarcoma. The patient and secondary care interval (SCI) offer the greatest potential for optimization, with SCI being the bottleneck of the diagnostic interval. New organizational structures for care work-ups are needed, such as integrated practice units (IPU) as integral part of value-based healthcare (VBHC).
doi_str_mv 10.3390/cancers15194892
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10571532</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A771811891</galeid><sourcerecordid>A771811891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-7d41b8f2741423ad5e8fc856bb8594a3fd4938f531f5cbad4a8fa92b612a2b483</originalsourceid><addsrcrecordid>eNptks9PHCEUgEmjqUY990rSSy-rw2_Gi9nYVZtsYpO2Z_qGgV3MDFiYbbP_fVk1rRrhwAt874NHHkIfSHPKWNucWYjW5UIEablu6Tt0SBtFZ1K2fO9ZfIBOSrlr6mCMKKneowOmNBNCy0P0cxHXVRPiCt84GKa1heywTxl_g2zTCPgrTMHFqZzjpSslxYJ9TiMG_DnAKqYyBbtj1n9gixfeB1tpu8XzCMO2hHKM9j0MxZ08rUfox9Xi--XNbHl7_eVyvpxZLuU0Uz0nnfZUccIpg1447a0Wsuu0aDkw3_OWaS8Y8cJ20HPQHlraSUKBdlyzI3Tx6L3fdKPrbX1yhsHc5zBC3poEwbw8iWFtVum3IY1QRDBaDZ-eDDn92rgymTEU64YBokubYqhWiun62aSiH1-hd2mTa8UPlOQNFU37n1rB4EyIPtWL7U5q5koRTYh-cJ2-QdXZuzHYFJ0Pdf9Fwtljgs2plOz8vyJJY3aNYV41BvsLIqSqrQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2876402509</pqid></control><display><type>article</type><title>Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Elyes, Maria ; Heesen, Philip ; Schelling, Georg ; Bode-Lesniewska, Beata ; Studer, Gabriela ; Fuchs, Bruno</creator><creatorcontrib>Elyes, Maria ; Heesen, Philip ; Schelling, Georg ; Bode-Lesniewska, Beata ; Studer, Gabriela ; Fuchs, Bruno</creatorcontrib><description>Sarcomas, rare and with lower survival rates than common tumors, offer insights into healthcare efficiency via the analysis of the total interval of the diagnostic pathway, combining the patient interval (time between the first symptom and visit with a physician) and diagnostic interval (time between first physician visit and histological diagnosis). Switzerland’s healthcare system, Europe’s costliest, lacks research on treating rare conditions, like mesenchymal tumors. This study examines the total interval of the diagnostic pathway for optimization strategies. Analyzing a dataset of 1028 patients presented from 2018 to 2021 to the Swiss Sarcoma Board (MDT/SB-SSN), this retrospective analysis delves into bone sarcoma (BS), soft-tissue sarcoma (STS), and their benign counterparts. Demographic and treatment data were extracted from medical records. The patient interval accounted for the largest proportion of the total interval and secondary care interval for the largest proportion of the diagnostic interval. Age, grade, and localization could be elicited as influencing factors of the length of different components of the total interval. An increasing age and tumor size, as well as the axial localization, could be elicited as factors increasing the probability of sarcoma. The patient and secondary care interval (SCI) offer the greatest potential for optimization, with SCI being the bottleneck of the diagnostic interval. New organizational structures for care work-ups are needed, such as integrated practice units (IPU) as integral part of value-based healthcare (VBHC).</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers15194892</identifier><identifier>PMID: 37835586</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Age ; Analysis ; Bone cancer ; Bone tumors ; Diagnosis ; Emergency medical care ; Family physicians ; Health care ; Health care policy ; Hospitals ; Localization ; Medical care, Cost of ; Medical records ; Medical referrals ; Patient satisfaction ; Patients ; Physicians ; Primary care ; Sarcoma ; Stem cells ; Tumors</subject><ispartof>Cancers, 2023-10, Vol.15 (19), p.4892</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-7d41b8f2741423ad5e8fc856bb8594a3fd4938f531f5cbad4a8fa92b612a2b483</citedby><cites>FETCH-LOGICAL-c466t-7d41b8f2741423ad5e8fc856bb8594a3fd4938f531f5cbad4a8fa92b612a2b483</cites><orcidid>0000-0002-5090-4935 ; 0000-0001-6453-3947 ; 0000-0002-3329-4186</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2876402509/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2876402509?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids></links><search><creatorcontrib>Elyes, Maria</creatorcontrib><creatorcontrib>Heesen, Philip</creatorcontrib><creatorcontrib>Schelling, Georg</creatorcontrib><creatorcontrib>Bode-Lesniewska, Beata</creatorcontrib><creatorcontrib>Studer, Gabriela</creatorcontrib><creatorcontrib>Fuchs, Bruno</creatorcontrib><title>Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis</title><title>Cancers</title><description>Sarcomas, rare and with lower survival rates than common tumors, offer insights into healthcare efficiency via the analysis of the total interval of the diagnostic pathway, combining the patient interval (time between the first symptom and visit with a physician) and diagnostic interval (time between first physician visit and histological diagnosis). Switzerland’s healthcare system, Europe’s costliest, lacks research on treating rare conditions, like mesenchymal tumors. This study examines the total interval of the diagnostic pathway for optimization strategies. Analyzing a dataset of 1028 patients presented from 2018 to 2021 to the Swiss Sarcoma Board (MDT/SB-SSN), this retrospective analysis delves into bone sarcoma (BS), soft-tissue sarcoma (STS), and their benign counterparts. Demographic and treatment data were extracted from medical records. The patient interval accounted for the largest proportion of the total interval and secondary care interval for the largest proportion of the diagnostic interval. Age, grade, and localization could be elicited as influencing factors of the length of different components of the total interval. An increasing age and tumor size, as well as the axial localization, could be elicited as factors increasing the probability of sarcoma. The patient and secondary care interval (SCI) offer the greatest potential for optimization, with SCI being the bottleneck of the diagnostic interval. New organizational structures for care work-ups are needed, such as integrated practice units (IPU) as integral part of value-based healthcare (VBHC).</description><subject>Age</subject><subject>Analysis</subject><subject>Bone cancer</subject><subject>Bone tumors</subject><subject>Diagnosis</subject><subject>Emergency medical care</subject><subject>Family physicians</subject><subject>Health care</subject><subject>Health care policy</subject><subject>Hospitals</subject><subject>Localization</subject><subject>Medical care, Cost of</subject><subject>Medical records</subject><subject>Medical referrals</subject><subject>Patient satisfaction</subject><subject>Patients</subject><subject>Physicians</subject><subject>Primary care</subject><subject>Sarcoma</subject><subject>Stem cells</subject><subject>Tumors</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptks9PHCEUgEmjqUY990rSSy-rw2_Gi9nYVZtsYpO2Z_qGgV3MDFiYbbP_fVk1rRrhwAt874NHHkIfSHPKWNucWYjW5UIEablu6Tt0SBtFZ1K2fO9ZfIBOSrlr6mCMKKneowOmNBNCy0P0cxHXVRPiCt84GKa1heywTxl_g2zTCPgrTMHFqZzjpSslxYJ9TiMG_DnAKqYyBbtj1n9gixfeB1tpu8XzCMO2hHKM9j0MxZ08rUfox9Xi--XNbHl7_eVyvpxZLuU0Uz0nnfZUccIpg1447a0Wsuu0aDkw3_OWaS8Y8cJ20HPQHlraSUKBdlyzI3Tx6L3fdKPrbX1yhsHc5zBC3poEwbw8iWFtVum3IY1QRDBaDZ-eDDn92rgymTEU64YBokubYqhWiun62aSiH1-hd2mTa8UPlOQNFU37n1rB4EyIPtWL7U5q5koRTYh-cJ2-QdXZuzHYFJ0Pdf9Fwtljgs2plOz8vyJJY3aNYV41BvsLIqSqrQ</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Elyes, Maria</creator><creator>Heesen, Philip</creator><creator>Schelling, Georg</creator><creator>Bode-Lesniewska, Beata</creator><creator>Studer, Gabriela</creator><creator>Fuchs, Bruno</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5090-4935</orcidid><orcidid>https://orcid.org/0000-0001-6453-3947</orcidid><orcidid>https://orcid.org/0000-0002-3329-4186</orcidid></search><sort><creationdate>20231001</creationdate><title>Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis</title><author>Elyes, Maria ; Heesen, Philip ; Schelling, Georg ; Bode-Lesniewska, Beata ; Studer, Gabriela ; Fuchs, Bruno</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-7d41b8f2741423ad5e8fc856bb8594a3fd4938f531f5cbad4a8fa92b612a2b483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age</topic><topic>Analysis</topic><topic>Bone cancer</topic><topic>Bone tumors</topic><topic>Diagnosis</topic><topic>Emergency medical care</topic><topic>Family physicians</topic><topic>Health care</topic><topic>Health care policy</topic><topic>Hospitals</topic><topic>Localization</topic><topic>Medical care, Cost of</topic><topic>Medical records</topic><topic>Medical referrals</topic><topic>Patient satisfaction</topic><topic>Patients</topic><topic>Physicians</topic><topic>Primary care</topic><topic>Sarcoma</topic><topic>Stem cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elyes, Maria</creatorcontrib><creatorcontrib>Heesen, Philip</creatorcontrib><creatorcontrib>Schelling, Georg</creatorcontrib><creatorcontrib>Bode-Lesniewska, Beata</creatorcontrib><creatorcontrib>Studer, Gabriela</creatorcontrib><creatorcontrib>Fuchs, Bruno</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>ProQuest research library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elyes, Maria</au><au>Heesen, Philip</au><au>Schelling, Georg</au><au>Bode-Lesniewska, Beata</au><au>Studer, Gabriela</au><au>Fuchs, Bruno</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis</atitle><jtitle>Cancers</jtitle><date>2023-10-01</date><risdate>2023</risdate><volume>15</volume><issue>19</issue><spage>4892</spage><pages>4892-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Sarcomas, rare and with lower survival rates than common tumors, offer insights into healthcare efficiency via the analysis of the total interval of the diagnostic pathway, combining the patient interval (time between the first symptom and visit with a physician) and diagnostic interval (time between first physician visit and histological diagnosis). Switzerland’s healthcare system, Europe’s costliest, lacks research on treating rare conditions, like mesenchymal tumors. This study examines the total interval of the diagnostic pathway for optimization strategies. Analyzing a dataset of 1028 patients presented from 2018 to 2021 to the Swiss Sarcoma Board (MDT/SB-SSN), this retrospective analysis delves into bone sarcoma (BS), soft-tissue sarcoma (STS), and their benign counterparts. Demographic and treatment data were extracted from medical records. The patient interval accounted for the largest proportion of the total interval and secondary care interval for the largest proportion of the diagnostic interval. Age, grade, and localization could be elicited as influencing factors of the length of different components of the total interval. An increasing age and tumor size, as well as the axial localization, could be elicited as factors increasing the probability of sarcoma. The patient and secondary care interval (SCI) offer the greatest potential for optimization, with SCI being the bottleneck of the diagnostic interval. New organizational structures for care work-ups are needed, such as integrated practice units (IPU) as integral part of value-based healthcare (VBHC).</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37835586</pmid><doi>10.3390/cancers15194892</doi><orcidid>https://orcid.org/0000-0002-5090-4935</orcidid><orcidid>https://orcid.org/0000-0001-6453-3947</orcidid><orcidid>https://orcid.org/0000-0002-3329-4186</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2023-10, Vol.15 (19), p.4892
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10571532
source Open Access: PubMed Central; Publicly Available Content Database (Proquest) (PQ_SDU_P3)
subjects Age
Analysis
Bone cancer
Bone tumors
Diagnosis
Emergency medical care
Family physicians
Health care
Health care policy
Hospitals
Localization
Medical care, Cost of
Medical records
Medical referrals
Patient satisfaction
Patients
Physicians
Primary care
Sarcoma
Stem cells
Tumors
title Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A45%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancing%20Healthcare%20for%20Sarcoma%20Patients:%20Lessons%20from%20a%20Diagnostic%20Pathway%20Efficiency%20Analysis&rft.jtitle=Cancers&rft.au=Elyes,%20Maria&rft.date=2023-10-01&rft.volume=15&rft.issue=19&rft.spage=4892&rft.pages=4892-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers15194892&rft_dat=%3Cgale_pubme%3EA771811891%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c466t-7d41b8f2741423ad5e8fc856bb8594a3fd4938f531f5cbad4a8fa92b612a2b483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2876402509&rft_id=info:pmid/37835586&rft_galeid=A771811891&rfr_iscdi=true